Burning Rock Biotech (BNR) Enterprise Value (2019 - 2026)

Burning Rock Biotech (BNR) has reported Enterprise Value for 8 consecutive years, with -$65.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value rose 5.18% year-over-year to -$65.2 million; the TTM figure through Mar 2026 stood at -$65.2 million (up 5.18% YoY), while the FY2025 annual figure was -$69.2 million, up 3.72% from the prior year.
• Enterprise Value came in at -$65.2 million for Q1 2026 at Burning Rock Biotech, up from -$67.8 million in the prior quarter.
• The five-year high for Enterprise Value was -$63.2 million in Q2 2025, with the low at -$200.9 million in Q1 2022.
• Average Enterprise Value over 5 years is -$98.2 million, with a median of -$79.3 million recorded in 2024.
• Across the five-year window, Enterprise Value surged 45.03% in 2022 and advanced 5.18% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$130.1 million in 2022, then jumped by 34.32% to -$85.4 million in 2023, then gained by 14.92% to -$72.7 million in 2024, then climbed by 6.69% to -$67.8 million in 2025, then climbed by 3.91% to -$65.2 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$65.2 million, -$67.8 million, and -$65.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.